Stock listing

NASDAQ:MIST Milestone Pharmaceuticals Inc. Stock

Home listing (NASDAQ) of Milestone Pharmaceuticals Inc.

Follow Milestone Pharmaceuticals Inc. into a list and get an email when it puts out news.

Share price · NASDAQ:MIST

$0.788 USD +0.022 (+2.9%)

Close on Oct 14, 2026

Milestone Pharmaceuticals Inc. logo
Ticker
NASDAQ:MIST
Asset type
Stock
Exchange
NASDAQ
Currency
USD

What changed lately

Calls

Replays

  • Milestone Pharmaceuticals (NASDAQ:MIST) Q2 2026 Earnings Call

    Wed, Aug 12, 2026 · 8:30 AM ET

    Watch Transcript

  • Milestone Pharmaceuticals (NASDAQ:MIST) Q1 2026 Earnings Call

    Wed, May 13, 2026 · 8:30 AM ET

    Watch Transcript

  • Milestone Pharmaceuticals (NASDAQ:MIST) Q4 2025 Earnings Call

    Fri, Mar 20, 2026 · 8:30 AM ET

    Watch Transcript

Latest news

Milestone Pharmaceuticals Announces First European Study Participant Enrolled in ReVeRA-301 Phase 3 Clinical Trial

Oct 9, 2026

Milestone Pharmaceuticals Announces NMPA Approval of Etripamil Nasal Spray for PSVT in China, Marking First Regulatory Approval of Etripamil Outside of the United States

Sep 3, 2026

Milestone Pharmaceuticals to Present at Upcoming Investor Conferences

Sep 2, 2026

Milestone Pharmaceuticals Announces Data Presented at ESC Congress 2026 on the Impact of Paroxysmal Supraventricular Tachycardia (PSVT) on Patients’ Daily Lives and Quality of Life Between Episodes

Aug 27, 2026

Milestone Pharmaceuticals Initiates Pivotal Phase 3 Trial of Etripamil Nasal Spray for Self-Administered Treatment of Atrial Fibrillation with Rapid Ventricular Rate (AFib-RVR)

Aug 21, 2026

Milestone Pharmaceuticals Announces Second Quarter 2026 Financial Results and Provides Corporate Update

Aug 12, 2026

Milestone Pharmaceuticals to Announce Second Quarter 2026 Financial Results on August 12, 2026

Aug 4, 2026

Milestone Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - July 2, 2026

Jul 6, 2026

Milestone Pharmaceuticals Announces First Quarter 2026 Financial Results and Provides Corporate Update

May 13, 2026

Milestone Pharmaceuticals to Announce First Quarter 2026 Financial Results on May 13, 2026

May 6, 2026

All Milestone Pharmaceuticals Inc. news

Decks

Milestone Pharmaceuticals Inc. on 6ix

News releases
27 in the last 12 months · 102 in all · newest Oct 9, 2026 · oldest 2019
Calls
4 calls with a replay · 4 with a transcript · latest Aug 12, 2026
Decks
16 decks · latest Aug 12, 2026

Where Milestone Pharmaceuticals Inc. is listed

ListingExchangeCountryCurrency
NASDAQ:MIST · Home listing · This pageNASDAQUnited StatesUSD
BOATS:MISTBOATSUnited StatesUSD

Log in to ask 6ix AI your own questions about Milestone Pharmaceuticals Inc.